Vafseo is a medicine used to treat the symptoms of anaemia (low red blood cell counts) caused by chronic kidney disease (long-term, progressive decrease in the ability of the kidneys to work properly) in adult patients on dialysis (a technique for removing unwanted substances and excess fluid from the blood when the kidneys do not work well enough). Vafseo contains the active substance vadadustat.
Therapeutic Indication
### Therapeutic indication Vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (CKD) in adults on chronic maintenance dialysis.
Therapeutic Area (MeSH)
ATC Code
N/A
ATC Item
N/A
Pharmacotherapeutic Group
Antianemic preparations
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| vadadustat | N/A | Vadadustat |
| Vadadustat | N/A | Vadadustat |
EMA Name
Vafseo
Medicine Name
Vafseo
Aliases
N/A
